Providence Health & Services
Clinical trials sponsored by Providence Health & Services, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Supercharged immune cells take on incurable tumors Results expected Dec 2026 (estimated)
- New combo therapy aims to shrink head and neck tumors before surgery Results expected Jan 2027 (estimated)
- Custom-Made immune cells take on incurable tumors Results expected Apr 2027 (estimated)
- Experimental drug combo aims to shrink aggressive breast tumors before surgery Results expected Jun 2027 (estimated)
-
Experimental drug aims to supercharge immune system before cancer surgery
Disease control CompletedThis early-phase study tested a single dose of an experimental antibody (MEDI0562) given before surgery to 13 patients with advanced head and neck cancer or melanoma. The goal was to see if the drug safely activates the immune system to fight the cancer. Researchers compared givi…
Phase 1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New combo shrinks rectal tumors before surgery
Disease control CompletedThis study tested a shorter radiation course combined with TASOX chemotherapy in 13 people with stage II/III rectal cancer before surgery. The goal was to shrink tumors and make surgery more effective. Results showed the treatment was safe and helped reduce cancer stage, but ongo…
Phase 2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New immune booster shows promise in early breast cancer trial
Disease control CompletedThis study tested a new immune-boosting treatment called IRX-2 in 16 people with early stage breast cancer. The goal was to see if giving IRX-2 before chemotherapy is safe and helps the immune system fight the tumor. The treatment was given before surgery, and researchers looked …
Phase 1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Cold caps may keep hair during chemo
Symptom relief CompletedThis study tested whether wearing special cold caps (Penguin caps) during chemotherapy could prevent or reduce hair loss in people with early-stage breast cancer. Twelve participants used the caps while getting one of four common chemo regimens. The goal was to see if at least ha…
Sponsor: Providence Health & Services • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC